methotrexate has been researched along with Radiation Pneumonitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arriagada, R; Bourgier, C; Dunant, A; Heymann, S; Marsiglia, H; Mathieu, MC; Pessoa, EL; Spielmann, M; Uzan, C | 1 |
Decramer, M; Erven, K; Fieuws, S; Lievens, Y; Nackaerts, K; Weltens, C | 1 |
Ashley, S; Fernando, IN; Ford, HT; Grafton, D; Harmer, CL; Powles, TJ | 1 |
Clough, R; Fan, M; Hardenbergh, PH; Hernando, ML; Hollis, D; Lind, PA; Lucas, D; Marks, LB; Piepgrass, A; Prosnitz, LR | 1 |
1 trial(s) available for methotrexate and Radiation Pneumonitis
Article | Year |
---|---|
An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Multivariate Analysis; Radiation Injuries; Radiation Pneumonitis; Random Allocation; Skin | 1996 |
3 other study(ies) available for methotrexate and Radiation Pneumonitis
Article | Year |
---|---|
Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heart; Humans; Inflammatory Breast Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiation Pneumonitis; Survival Rate; Tamoxifen; Time Factors; Vincristine | 2012 |
Changes in pulmonary function up to 10 years after locoregional breast irradiation.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbon Monoxide; Cyclophosphamide; Female; Fluorouracil; Forced Expiratory Volume; Humans; Lung; Methotrexate; Middle Aged; Pulmonary Diffusing Capacity; Radiation Pneumonitis; Recovery of Function; Respiratory Function Tests; Tamoxifen; Time Factors; Total Lung Capacity; Vital Capacity | 2012 |
Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Lymphatic Irradiation; Methotrexate; Radiation Pneumonitis; Radiography; Regression Analysis | 2002 |